vorinostat has been researched along with Cell Transformation, Viral in 2 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Cell Transformation, Viral: An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z | 1 |
| Lopez-Ramos, DA | 1 |
| Yoshihara, E | 1 |
| Maeda, Y | 1 |
| Masutani, H | 2 |
| Sugie, K | 1 |
| Maeda, M | 2 |
| Yodoi, J | 2 |
| Ahsan, MK | 1 |
| Yamaguchi, Y | 1 |
| Kim, YC | 1 |
| Nosaka, K | 1 |
| Matsuoka, M | 1 |
| Nishinaka, Y | 1 |
2 other studies available for vorinostat and Cell Transformation, Viral
| Article | Year |
|---|---|
Thioredoxin-binding protein-2 (TBP-2/VDUP1/TXNIP) regulates T-cell sensitivity to glucocorticoid during HTLV-I-induced transformation.
Topics: Carrier Proteins; Cell Line; Cell Transformation, Viral; Glucocorticoids; Human T-lymphotropic virus | 2011 |
Loss of interleukin-2-dependency in HTLV-I-infected T cells on gene silencing of thioredoxin-binding protein-2.
Topics: Acetylation; Azacitidine; Carrier Proteins; Cell Line, Tumor; Cell Transformation, Viral; Chromatin | 2006 |